110 related articles for article (PubMed ID: 29735425)
1. Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators.
Gerlach K; Hobson S; Eickmeier C; Groß U; Braun C; Sieger P; Garneau M; Hoerer S; Heine N
Bioorg Med Chem; 2018 Jul; 26(12):3227-3241. PubMed ID: 29735425
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.
Bischoff F; Berthelot D; De Cleyn M; Macdonald G; Minne G; Oehlrich D; Pieters S; Surkyn M; Trabanco AA; Tresadern G; Van Brandt S; Velter I; Zaja M; Borghys H; Masungi C; Mercken M; Gijsen HJ
J Med Chem; 2012 Nov; 55(21):9089-106. PubMed ID: 22650177
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of aminothiazole modulators of the gamma-secretase enzyme.
Rynearson KD; Buckle RN; Barnes KD; Herr RJ; Mayhew NJ; Paquette WD; Sakwa SA; Nguyen PD; Johnson G; Tanzi RE; Wagner SL
Bioorg Med Chem Lett; 2016 Aug; 26(16):3928-37. PubMed ID: 27426299
[TBL] [Abstract][Full Text] [Related]
4. Optimization and biological evaluation of imidazopyridine derivatives as a novel scaffold for γ-secretase modulators with oral efficacy against cognitive deficits in Alzheimer's disease model mice.
Sekioka R; Honda S; Akashiba H; Yarimizu J; Mitani Y; Yamasaki S
Bioorg Med Chem; 2020 Jun; 28(11):115455. PubMed ID: 32307259
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators.
Takai T; Hoashi Y; Tomata Y; Morimoto S; Nakamura M; Watanabe T; Igari T; Koike T
Bioorg Med Chem Lett; 2015 Oct; 25(19):4245-9. PubMed ID: 26298496
[TBL] [Abstract][Full Text] [Related]
6. Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators.
Qin J; Dhondi P; Huang X; Mandal M; Zhao Z; Pissarnitski D; Zhou W; Aslanian R; Zhu Z; Greenlee W; Clader J; Zhang L; Cohen-Williams M; Jones N; Hyde L; Palani A
Bioorg Med Chem Lett; 2011 Jan; 21(2):664-9. PubMed ID: 21195610
[TBL] [Abstract][Full Text] [Related]
7. Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.
Zettl H; Ness J; Hähnke V; Beher D; Jumpertz T; Saric A; Baumann K; Pietrzik CU; Bulic B; Schneider G; Weggen S
ACS Chem Biol; 2012 Sep; 7(9):1488-95. PubMed ID: 22725102
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel scaffolds for γ-secretase modulators without an arylimidazole moiety.
Sekioka R; Honjo E; Honda S; Fuji H; Akashiba H; Mitani Y; Yamasaki S
Bioorg Med Chem; 2018 Jan; 26(2):435-442. PubMed ID: 29249626
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of an aminopiperidine series of γ-secretase modulators.
Kobayashi T; Iwama S; Fusano A; Kato Y; Ikeda A; Teranishi Y; Nishihara A; Tobe M
Bioorg Med Chem Lett; 2014 Jan; 24(1):378-81. PubMed ID: 24269163
[TBL] [Abstract][Full Text] [Related]
10. Iminoheterocycles as gamma-secretase modulators.
Caldwell JP; Bennett CE; McCracken TM; Mazzola RD; Bara T; Buevich A; Burnett DA; Chu I; Cohen-Williams M; Josein H; Hyde L; Lee J; McKittrick B; Song L; Terracina G; Voigt J; Zhang L; Zhu Z
Bioorg Med Chem Lett; 2010 Sep; 20(18):5380-4. PubMed ID: 20724152
[TBL] [Abstract][Full Text] [Related]
11. Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's disease.
Brodney MA; Auperin DD; Becker SL; Bronk BS; Brown TM; Coffman KJ; Finley JE; Hicks CD; Karmilowicz MJ; Lanz TA; Liston D; Liu X; Martin BA; Nelson RB; Nolan CE; Oborski CE; Parker CP; Richter KE; Pozdnyakov N; Sahagan BG; Schachter JB; Sokolowski SA; Tate B; Van Deusen JW; Wood DE; Wood KM
Bioorg Med Chem Lett; 2011 May; 21(9):2631-6. PubMed ID: 21269825
[TBL] [Abstract][Full Text] [Related]
12. Triazoles as γ-secretase modulators.
Fischer C; Zultanski SL; Zhou H; Methot JL; Brown WC; Mampreian DM; Schell AJ; Shah S; Nuthall H; Hughes BL; Smotrov N; Kenific CM; Cruz JC; Walker D; Bouthillette M; Nikov GN; Savage DF; Jeliazkova-Mecheva VV; Diaz D; Szewczak AA; Bays N; Middleton RE; Munoz B; Shearman MS
Bioorg Med Chem Lett; 2011 Jul; 21(13):4083-7. PubMed ID: 21616665
[TBL] [Abstract][Full Text] [Related]
13. Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects.
Toyn JH; Boy KM; Raybon J; Meredith JE; Robertson AS; Guss V; Hoque N; Sweeney F; Zhuo X; Clarke W; Snow K; Denton RR; Zuev D; Thompson LA; Morrison J; Grace J; Berisha F; Furlong M; Wang JS; Lentz KA; Padmanabha R; Cook L; Wei C; Drexler DM; Macor JE; Albright CF; Gasior M; Olson RE; Hong Q; Soares HD; AbuTarif M; Ahlijanian MK
J Pharmacol Exp Ther; 2016 Jul; 358(1):125-37. PubMed ID: 27189974
[TBL] [Abstract][Full Text] [Related]
14. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach.
Xin Z; Peng H; Zhang A; Talreja T; Kumaravel G; Xu L; Rohde E; Jung MY; Shackett MN; Kocisko D; Chollate S; Dunah AW; Snodgrass-Belt PA; Arnold HM; Taveras AG; Rhodes KJ; Scannevin RH
Bioorg Med Chem Lett; 2011 Dec; 21(24):7277-80. PubMed ID: 22061640
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulators.
Bischoff FP; Velter AI; Minne G; Pieters S; Berthelot D; De Cleyn M; Gijsen HJM; Macdonald G; Surkyn M; Van Brandt S; Van Roosbroeck Y; Zavattaro C; Mercken M; Austin N; Dhuyvetter D; Borghys H; Ahmad I; Samanta SK
Bioorg Med Chem Lett; 2019 Jul; 29(14):1737-1745. PubMed ID: 31122869
[TBL] [Abstract][Full Text] [Related]
17. Triazoloamides as potent γ-secretase modulators with reduced hERG liability.
Fischer C; Zultanski SL; Zhou H; Methot JL; Shah S; Nuthall H; Hughes BL; Smotrov N; Hill A; Szewczak AA; Moxham CM; Bays N; Middleton RE; Munoz B; Shearman MS
Bioorg Med Chem Lett; 2012 May; 22(9):3140-6. PubMed ID: 22497762
[TBL] [Abstract][Full Text] [Related]
18. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer's Disease.
Bursavich MG; Harrison BA; Acharya R; Costa DE; Freeman EA; Hodgdon HE; Hrdlicka LA; Jin H; Kapadnis S; Moffit JS; Murphy DA; Nolan S; Patzke H; Tang C; Wen M; Koenig G; Blain JF; Burnett DA
J Med Chem; 2017 Mar; 60(6):2383-2400. PubMed ID: 28230986
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of piperazine derivatives as a novel class of γ-secretase modulators that selectively lower Aβ₄₂ production.
Takai T; Koike T; Honda E; Kajita Y; Nakamura M; Morimoto S; Hoashi Y; Kamata M; Watanabe T; Igari T; Terauchi J
Bioorg Med Chem; 2015 May; 23(9):1923-34. PubMed ID: 25842363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
